KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Goodwill: 2019-2023

Historic Goodwill for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Dec 2023 value amounting to $49.2 million.

  • Ginkgo Bioworks Holdings' Goodwill fell 18.42% to $47.9 million in Q1 2024 from the same period last year, while for Mar 2024 it was $47.9 million, marking a year-over-year decrease of 18.42%. This contributed to the annual value of $49.2 million for FY2023, which is 18.22% down from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Goodwill of $49.2 million as of FY2023, which was down 18.22% from $60.2 million recorded in FY2022.
  • In the past 5 years, Ginkgo Bioworks Holdings' Goodwill registered a high of $60.2 million during FY2022, and its lowest value of $1.9 million during FY2019.
  • For the 3-year period, Ginkgo Bioworks Holdings' Goodwill averaged around $43.6 million, with its median value being $49.2 million (2023).
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Goodwill soared by 1,047.66% in 2021, and later decreased by 18.22% in 2023.
  • Yearly analysis of 5 years shows Ginkgo Bioworks Holdings' Goodwill stood at $1.9 million in 2019, then remained steady at $1.9 million in 2020, then surged by 1,047.66% to $21.3 million in 2021, then surged by 182.52% to $60.2 million in 2022, then decreased by 18.22% to $49.2 million in 2023.